FR2696462B1
(fr)
*
|
1992-10-05 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé d'obtention de la désacétyl-10 baccatine III.
|
ATE420628T1
(de)
|
1993-07-19 |
2009-01-15 |
Angiotech Pharm Inc |
Anti-angiogene mittel und verfahren zu deren verwendung
|
WO1995012445A1
(de)
*
|
1993-11-02 |
1995-05-11 |
Rhône-Poulenc Rorer GmbH |
Verfahren und vorrichtung zum auftrennen eines gemisches
|
FR2714053B1
(fr)
*
|
1993-12-22 |
1996-03-08 |
Pf Medicament |
Procédé d'extraction et d'isolement de la 10-désacétylbaccatine III.
|
CN1112433A
(zh)
*
|
1994-05-24 |
1995-11-29 |
郭明 |
红豆杉属植物提取物及其应用
|
CA2178541C
(en)
|
1995-06-07 |
2009-11-24 |
Neal E. Fearnot |
Implantable medical device
|
FR2736355B1
(fr)
*
|
1995-07-07 |
1997-11-07 |
Pf Medicament |
Procede d'extraction et d'isolement de la 10-desacetylbaccatine iii
|
US5750736A
(en)
*
|
1996-07-11 |
1998-05-12 |
Napro Biotherapeutics, Inc. |
Method for acylating 10-deacetylbaccatin III selectively at the c-10 position
|
US5965752A
(en)
*
|
1996-08-23 |
1999-10-12 |
Institut National De La Recherche Scientifique |
Preparative scale isolation and purification of taxanes
|
DE69812395T2
(de)
|
1997-08-21 |
2004-02-05 |
Florida State University, Tallahassee |
Verfahren zur synthese von taxanen
|
US6002024A
(en)
*
|
1998-07-27 |
1999-12-14 |
Dabur Research Foundation |
Process for the isolation of 14β-hydroxy-10-deacetyl baccatin-III
|
US6136989A
(en)
*
|
1998-12-30 |
2000-10-24 |
Phytogen Life Sciences, Incorporated |
Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
|
US6495705B2
(en)
|
2000-03-16 |
2002-12-17 |
Napro Biotherapeutics, Inc. |
Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes
|
US6281368B1
(en)
|
2000-03-16 |
2001-08-28 |
Napro Biotherapeutics, Inc. |
Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities of taxanes to obtain 10-DAB III
|
CA2307393A1
(en)
|
2000-05-01 |
2001-11-01 |
The University Of British Columbia |
Ginsenoside chemotherapy
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
WO2002072150A2
(en)
|
2001-03-13 |
2002-09-19 |
Angiotech Pharmaceuticals Inc. |
Micellar drug delivery vehicles and uses thereof
|
ATE363898T1
(de)
|
2001-04-20 |
2007-06-15 |
Univ British Columbia |
Mizellares arzneistoffverabreichungssystem für hydrophobe arzneistoffe
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
JP2006516548A
(ja)
|
2002-12-30 |
2006-07-06 |
アンジオテック インターナショナル アクツィエン ゲゼルシャフト |
迅速ゲル化ポリマー組成物からの薬物送達法
|
JP2007525188A
(ja)
|
2003-05-16 |
2007-09-06 |
インターミューン インコーポレイテッド |
合成ケモカイン受容体リガンドおよびその使用方法
|
US8003122B2
(en)
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
US7989490B2
(en)
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
US7846940B2
(en)
|
2004-03-31 |
2010-12-07 |
Cordis Corporation |
Solution formulations of sirolimus and its analogs for CAD treatment
|
PL1778660T3
(pl)
*
|
2004-07-02 |
2009-07-31 |
Ivax Pharmaceuticals Sro |
Sposób rozdzielania paklitakselu i cefalomanniny
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
WO2006089218A2
(en)
|
2005-02-17 |
2006-08-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for modulating angiogenesis
|
WO2007062036A2
(en)
|
2005-11-21 |
2007-05-31 |
Med Institute, Inc. |
Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent
|
US8168216B2
(en)
|
2006-03-22 |
2012-05-01 |
Medigene Ag |
Treatment of triple receptor negative breast cancer
|
EP2043704B2
(en)
|
2006-06-30 |
2017-04-19 |
Cook Medical Technologies LLC |
Methods of manufacturing and modifying taxane coatings for implantable medical devices
|
US8409601B2
(en)
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
US8420110B2
(en)
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
US8273404B2
(en)
|
2008-05-19 |
2012-09-25 |
Cordis Corporation |
Extraction of solvents from drug containing polymer reservoirs
|
EP2859916B1
(en)
|
2008-05-22 |
2017-11-29 |
Galera Labs, LLC |
Combination of an antimitotic agent and a selective superoxide dismutase mimetic in antitumor therapy
|
WO2010005850A1
(en)
|
2008-07-08 |
2010-01-14 |
The J. David Gladstone Institutes |
Methods and compositions for modulating angiogenesis
|
US8642063B2
(en)
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
US20120302954A1
(en)
|
2011-05-25 |
2012-11-29 |
Zhao Jonathon Z |
Expandable devices coated with a paclitaxel composition
|
US20120303115A1
(en)
|
2011-05-25 |
2012-11-29 |
Dadino Ronald C |
Expandable devices coated with a rapamycin composition
|
EP2760848B1
(en)
|
2011-09-26 |
2018-11-28 |
Fresenius Kabi Oncology Limited |
Processes for the preparation of cabazitaxel involving c(7)-oh and c(13)-oh silylation or just c(7)-oh silylation
|
US9956385B2
(en)
|
2012-06-28 |
2018-05-01 |
The Spectranetics Corporation |
Post-processing of a medical device to control morphology and mechanical properties
|
US9181343B2
(en)
|
2012-07-19 |
2015-11-10 |
Redwood Bioscience Inc. |
Antibody specific for CD22 and methods of use thereof
|
CA2890190A1
(en)
|
2012-11-12 |
2014-05-15 |
Redwood Bioscience, Inc. |
Compounds and methods for producing a conjugate
|
CN103804326A
(zh)
*
|
2012-11-15 |
2014-05-21 |
刘胜远 |
一种从含10-去乙酰基巴卡亭ⅲ的浸膏分离和提纯10-去乙酰基巴卡亭ⅲ的方法
|
CA2901115A1
(en)
|
2013-02-15 |
2014-08-21 |
The Regents Of The University Of California |
Heterodimeric conditionally active chimeric antigen receptor and methods of use thereof
|
CN103145652B
(zh)
*
|
2013-03-05 |
2015-09-30 |
无锡尔云科技有限公司 |
一种从红豆杉属植物中提取紫杉醇及其衍生物的方法
|
CN105358531B
(zh)
|
2013-03-14 |
2017-11-14 |
利兰-斯坦福大学初级学院的董事会 |
线粒体醛脱氢酶‑2调节剂和其使用方法
|
JP6745218B2
(ja)
|
2013-11-27 |
2020-08-26 |
レッドウッド バイオサイエンス, インコーポレイテッド |
ヒドラジニル−ピロロ化合物及び複合体を生成するための方法
|
PL3107899T3
(pl)
|
2014-02-19 |
2021-01-25 |
Aviv Therapeutics, Inc. |
Policykliczne amidy wiążące mitochondrialną dehydrogenazę aldehydową-2 (aldh2) i ich zastosowanie w leczeniu nowotworów
|
EP3352796A4
(en)
|
2015-09-25 |
2019-05-01 |
ZY Therapeutics Inc. |
PARTICLE-BASED MEDICINAL FORMULATION COMPRISING A POLYSACCHARIDE-VITAMIN CONJUGATE
|
EP3373977A4
(en)
|
2015-11-12 |
2019-07-17 |
The Board of Trustees of the Leland Stanford Junior University |
CELLULAR PENETRATION-RICH GUANIDINIC OLIGOPHOSPHOTRIESTERS FOR THE DELIVERY OF MEDICATION AND PROBE
|
TWI760319B
(zh)
|
2015-12-30 |
2022-04-11 |
杏國新藥股份有限公司 |
乳癌治療
|
JP2019515677A
(ja)
|
2016-04-26 |
2019-06-13 |
アール.ピー.シェーラー テクノロジーズ エルエルシー |
抗体複合体ならびにそれを作製および使用する方法
|
EP3463308B1
(en)
|
2016-06-01 |
2021-12-01 |
Servier IP UK Limited |
Formulations of polyalkylene oxide-asparaginase and methods of making and using the same
|
TW201825087A
(zh)
|
2017-01-05 |
2018-07-16 |
杏國新藥股份有限公司 |
胰臟癌治療
|
MX2019008503A
(es)
|
2017-01-18 |
2019-09-13 |
F1 Oncology Inc |
Receptores de antigenos quimericos contra axl o ror2 y metodos de uso de los mismos.
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
KR20200118823A
(ko)
|
2018-01-31 |
2020-10-16 |
갈레라 랩스, 엘엘씨 |
펜타아자 마크로시클릭 고리 복합체 및 백금-기재 항암제를 사용한 조합 암 요법
|
CN112368011A
(zh)
|
2018-04-11 |
2021-02-12 |
俄亥俄州创新基金会 |
缓释微粒用于眼用药物递送的方法和组合物
|
CN108904137A
(zh)
*
|
2018-05-27 |
2018-11-30 |
肖军威 |
一种卫生巾芯片的制备方法及卫生巾芯片的加工设备
|
JP2021530507A
(ja)
|
2018-07-18 |
2021-11-11 |
マンザニータ ファーマシューティカルズ,インク. |
神経細胞に抗がん剤を送達するためのコンジュゲート、その使用方法及び製造方法
|
US11529402B2
(en)
|
2019-01-14 |
2022-12-20 |
Ignite Immunotherapy, Inc. |
Recombinant vaccinia virus and methods of use thereof
|
WO2020165730A1
(en)
|
2019-02-14 |
2020-08-20 |
Ignite Immunotherapy, Inc. |
Recombinant vaccinia virus and methods of use thereof
|
AU2020253449A1
(en)
|
2019-04-02 |
2021-11-18 |
Kenjockety Biotechnology, Inc. |
Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
|
CN110317183B
(zh)
*
|
2019-08-08 |
2021-03-12 |
无锡紫杉药业有限公司 |
一种红豆杉天然提取产物的纯化方法
|
CA3163805A1
(en)
|
2019-12-12 |
2021-06-17 |
Ignite Immunotherapy, Inc. |
Variant oncolytic vaccinia virus and methods of use thereof
|
BR112022013870A2
(pt)
|
2020-01-29 |
2022-09-13 |
Kenjockety Biotechnology Inc |
Anticorpos anti-mdr1 e usos dos mesmos
|
AU2021283080A1
(en)
|
2020-06-04 |
2022-12-15 |
Kenjockety Biotechnology, Inc. |
ABCG2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
|
US20230212305A1
(en)
|
2020-06-04 |
2023-07-06 |
Kenjockety Biotechnology, Inc. |
Anti-abcg2 antibodies and uses thereof
|
KR20230023032A
(ko)
|
2020-07-14 |
2023-02-16 |
화이자 인코포레이티드 |
재조합 백시니아 바이러스
|
CN116490522A
(zh)
|
2020-09-02 |
2023-07-25 |
肯乔克蒂生物技术股份有限公司 |
抗abcc1抗体及其应用
|
US20240010747A1
(en)
|
2020-11-13 |
2024-01-11 |
Kenjockety Biotechnology, Inc. |
Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
|
CN112694458A
(zh)
*
|
2020-12-29 |
2021-04-23 |
重庆臻源红豆杉发展有限公司 |
一种10-去乙酰基巴卡亭ⅲ提取纯化方法
|
WO2023114658A1
(en)
|
2021-12-13 |
2023-06-22 |
Kenjockety Biotechnology, Inc. |
Anti-abcb1 antibodies
|
WO2023159220A1
(en)
|
2022-02-18 |
2023-08-24 |
Kenjockety Biotechnology, Inc. |
Anti-cd47 antibodies
|